Long COVID: New Research and the Economic Toll
Time & Location
As we enter the third COVID winter, nearly 1 in 3 adults in the US that had COVID-19 also reported experiencing symptoms of long COVID at some point. Emerging research illustrates that long COVID is not just a health problem — it’s an economic one too, disrupting patients’ lives for years to come. Research has found that the economic losses of long COVID could be as high as $3.7 trillion, when factoring in the lost quality of life, the cost in lost earnings, and the cost of higher spending on medical care. Pinpointing the underlying causes of this new and emerging illness has continued to be difficult, and could make treatment costly. Many people fear that the same factors that caused racial and ethnic disparities during COVID-19 may be responsible for driving disparities in the treatment of long COVID. This webinar will explore:
New and emerging data on long COVID and what is currently understood and known about long COVID.
How to protect people from COVID and understanding the economic burden of long COVID.
A health plan’s efforts to connect individuals suffering from long COVID to care and other resources equitably.
Walter Koroshetz, MD
National Institutes of Health
David Cutler, PhD
Kelli Tice, MD